Luvox - Fluvoxamine
5 customer reviewsLuvox is an SSRI antidepressant containing fluvoxamine. It is used for conditions such as obsessive-compulsive disorder and social anxiety disorder. It helps by increasing serotonin signalling in the brain over time.
What is it?
Luvox is the brand name for fluvoxamine (also used as fluvoxamine maleate in many tablet formulations). It belongs to the antidepressant class called selective serotonin reuptake inhibitors (SSRIs). SSRIs act on serotonin, a neurotransmitter involved in mood, anxiety, sleep, and repetitive thought patterns.
In simple terms, nerve cells normally “recycle” serotonin back inside the cell after it is released. Luvox slows that recycling (the “reuptake”), so more serotonin remains available between nerve cells, supporting a steadier emotional baseline and fewer anxiety-driven loops. This serotonergic effect is gradual; for many patients the first clear benefits show after a few weeks of consistent daily dosing. Evidence reviews used by regulators and guideline bodies support SSRIs, including fluvoxamine, in anxiety-spectrum disorders and OCD care pathways. [1]
Composition
Luvox is the brand name for fluvoxamine (also used as fluvoxamine maleate in many tablet formulations). It belongs to the antidepressant class called selective serotonin reuptake inhibitors (SSRIs).
How to use?
Luvox tablets are taken by mouth, usually once daily in the evening or twice daily, depending on the condition, symptom severity, and tolerability. Prescribers often start low and increase gradually to reduce early side effects.
Practical administration points:
- Swallow the tablet with water.
- Take it at a consistent time each day.
- It can be taken with or without food, though food may help nausea for some people.
- If a dose is missed, take it when remembered unless the next dose is near; in that case, skip the missed dose and return to the normal schedule.
How does it work?
- Route: take Luvox tablets orally with water.
- Dose: start at 50 mg once daily; if needed, the dose may be increased by 50 mg every 4 to 7 days.
- Frequency: usually 1 time/day at bedtime, or 2 times/day if higher total daily doses are prescribed.
- Timing: take with or after meals if stomach upset occurs; swallow the tablet whole.
- Duration: continue daily for several weeks or longer as directed by a clinician; do not stop suddenly.
Indications
Luvox is an antidepressant (SSRI) used in mental health care, with strongest recognition for:
- Obsessive-compulsive disorder (OCD): intrusive thoughts, compulsive checking/washing, mental rituals, reassurance seeking.
- Social Anxiety Disorder: fear of social evaluation, avoidance, physical anxiety symptoms in social settings.
Doctors also use SSRIs like fluvoxamine for broader anxiety and depressive symptoms when they overlap with OCD traits (rumination, repetitive worry, sleep disruption). Treatment response is usually measured as changes in day-to-day function: time spent on rituals, ability to attend work, reduced avoidance, and improved sleep continuity. [2]
Comparison
If Luvox is not a good match, doctors usually consider other SSRIs or SNRIs for OCD and social anxiety, guided by past response and tolerability. Common options in the same treatment space include Zoloft (sertraline), Celexa (citalopram), Lexapro (escitalopram), Paxil (paroxetine), and Effexor (venlafaxine); some clinicians also use mirtazapine (the active ingredient in Remeron) for anxiety with insomnia.
Luvox Compared with Other Antidepressant Options
| Option | Usual clinical role | Typical trade-offs |
|---|---|---|
| Luvox (fluvoxamine) | Strong focus on OCD/social anxiety | Interaction screening is essential; GI and sleep effects early |
| Other SSRIs (sertraline, escitalopram, paroxetine, citalopram) | Broad anxiety/depression use | Sexual side effects and activation/sedation vary by drug |
| SNRIs (venlafaxine) | Anxiety with low energy or comorbid pain | Blood pressure and withdrawal effects can be more prominent |
Contraindications
- Allergy or hypersensitivity to fluvoxamine (or tablet excipients).
- Current use of monoamine oxidase inhibitors (MAOIs), or use within the last 14 days.
- Severe liver failure where fluvoxamine exposure may rise to unsafe levels.
- Breastfeeding when continuation is not clinically appropriate due to infant exposure risk.
- Use in people under 18 for depression where safety/efficacy has not been established for that indication (specialist decisions differ by case and diagnosis).
- Bipolar disorder or past manic episodes requires prescriber screening because SSRIs can trigger mood elevation in some patients.
Not recommended for
Luvox needs extra caution if you have liver disease, a seizure history, or a tendency toward low sodium. It also needs a careful discussion if you are pregnant, breastfeeding, or treating a child, teenager, or older adult. If you stop it suddenly, withdrawal symptoms can happen and the prescriber may need to taper the dose.
Side effects
Side effects tend to cluster in the first days to weeks, then ease as the body adapts. The most reported issues with fluvoxamine include nausea, GI upset, headache, dry mouth, sleepiness or insomnia, weight change, and sexual side effects.
Common side effects (often early, often dose-related):
- Nausea or vomiting
- Headache
- Dry mouth
- Drowsiness or insomnia
- Reduced libido or delayed orgasm
- Weight changes (gain or loss)
Serious side effects to recognise quickly:
- Serotonin syndrome (a toxic excess of serotonergic activity), which can present with agitation, confusion, sweating, fever, fast heart rate, tremor, muscle stiffness, diarrhoea, and poor coordination. This is more likely when Luvox is combined with other serotonergic drugs.
- Worsening depression or suicidal thinking early in treatment can occur in a minority of patients, a recognised SSRI class warning.
- Unusual bleeding or easy bruising can occur, especially if combined with medicines that affect clotting.
One detail patients often miss: sexual side effects can be subtle at first, then become obvious after the mood improves. Bringing it up early helps the prescriber adjust strategy.
Common mistakes
People rarely fail because the medicine “doesn’t work.” They fail because the routine breaks.
- Stopping after a week because of nausea, without trying food timing or a slower titration plan.
- Doubling a dose after a missed tablet, then feeling shaky or nauseated for 24 hours.
- Adding an SSRI/SNRI from an old prescription while still on Luvox, increasing serotonin syndrome risk.
- Changing dose timing day-to-day, which can make sleep problems drag on.
- Hiding sexual side effects until they become a relationship crisis; dose strategy changes exist, but only if the prescriber knows.
Doctor opinions
In clinical practice, Luvox is often selected when OCD symptoms are central: intrusive thoughts, compulsions, and the “stuck” feeling that does not respond well to reassurance. Many psychiatrists also like that fluvoxamine can be paired with structured therapy, such as exposure and response prevention (ERP), because medication can lower baseline anxiety enough for patients to do the hard behavioural work.
Frequently asked questions
Symptom relief is usually gradual, with many people noticing first changes in sleep or anxiety within a few weeks, and fuller OCD improvement taking longer. OCD often needs higher doses and longer trials than depression, so the timeline can extend beyond the first month. WHO mental health guidance continues to describe antidepressants as treatments that require consistent dosing and follow-up rather than rapid symptom reversal. [4]
Luvox is not considered addictive in the way benzodiazepines or opioids are, and it does not produce cravings or dose escalation for a “high.” Some patients do get discontinuation symptoms if they stop suddenly, which can feel intense but reflects serotonin adaptation, not addiction. EMA regulatory documents for SSRIs describe tapering strategies to reduce discontinuation symptoms. [5]
Take the missed dose when you remember unless the next dose is close; if it is close, skip the missed dose and return to the regular schedule. Doubling up is a common reason people feel shaky, nauseated, or unable to sleep the next day. MOHAP-aligned medication counselling in UAE practice prioritises avoiding dose “catch-up” for psychotropics because side effects rise with sudden peaks.
Fluvoxamine can pass into breast milk, so infants exposed to fluvoxamine through breast milk may be at risk of side effects like irritability or feeding changes. The decision is individual and weighs maternal mental health needs against infant risk, and alternatives may be considered. EMA product information sources for SSRIs discuss lactation exposure as a key counselling point.
MAOIs are the highest-risk group because of serotonin syndrome, and combinations are avoided with a washout period. Thioridazine is also avoided due to serious interaction risk. Many antidepressants (Paxil, Celexa, Zoloft, Lexapro, Effexor), lithium, clozapine, doxepin, nortriptyline, and imipramine can require careful planning, dose adjustment, or monitoring because fluvoxamine can alter drug levels and serotonergic effects.
Front view
Side view
Back view
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
Luvox — Comparison with alternatives
Luvox Current
Anafranil
Zoloft Best price
Pristiq Best rated
Paxil
Reviews and Experiences
Sources
- National Institute for Health and Care Excellence (NICE) (2025). Obsessive-compulsive disorder and body dysmorphic disorder: treatment (clinical guidance and evidence updates). ↑
- American Psychiatric Association (APA) (2025). Practice guideline for the treatment of patients with obsessive-compulsive disorder (updated guidance). ↑
- MOHAP (Ministry of Health and Prevention) (2026). Medication safety communications and pharmacovigilance guidance (public information and safety updates). ↑
- World Health Organization (WHO) (2025). Guidelines on mental health conditions: management of depression and anxiety in non-specialized health settings. ↑
- European Medicines Agency (EMA) (2025). Summary of Product Characteristics (SmPC) — fluvoxamine (SSRI). ↑